MANNYCEF

This brand name is authorized in Nigeria.

Active ingredients

The drug MANNYCEF contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Sulbactam UNII DKQ4T82YE6 - SULBACTAM SODIUM
	Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9362	Injection	MANNYCEF INJECTION INJ 1000 mg; 500 mg 1 X 1VIAL + 1 AMPOULE OF 3.5ML LIDOCAINE HYDROCHLORIDE INJECTION (1%W/V)	MANNYCEF INJECTION MANNYCEF STERILE CEFTRIAXONE SODIUM USP EQ. TO ANYHYDROUS CEFTRIAXONE 1000MG, STERILE SULBACTAM SODIUM USP EQ. TO SULBACTAM 500MG, METHYLPRABEN BP 0.1%W/V (AS PRESERVATIVE) POM INJECTION 1 X 1VIAL + 1 AMPOULE OF 3.5ML LIDOCAINE HYDROCHLORIDE INJECTION (1%W/V) ANTIBIOTIC MANNY GLOBAL PHARMA LTD 1, OLAOSEBIKAN STREET OKOTA, LAGOS STATE NITIN LIFESCIENCES LTD RAMPUR ROAD, PAONTA SAHIB DISTT. SIMOUR (H.P)-173025, INDIA GMP- SATIS; LR- SATIS; FEES- PAID; NP: NA 19/06/2018 R R R B4-9362	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD63		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD63

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9362